New hires:
Alison Chartan left Novavax to become director of communications at Bristol Myers Squibb.
Generate:Biomedicines appointed Kimberly (Kym) White as chief corporate affairs officer.
Stoke Therapeutics appointed Thomas Leggett as CFO.
Saama named Ari Srinivasan, a former executive at Real Chemistry, as chief customer success and growth officer.
Barinthus Bio named Leon Hooftman, MD as chief medical officer.
Akero Therapeutics hired Scott Gangloff as chief technology officer.
Evotec named Christian Wojczewski as CEO, replacing interim CEO Mario Polywka in July.
Independent healthcare marketing agency The Considered added Diego Freitas and Mauro Arruda as global creative partners.
United BioSource hired Anthony Luttenberger as chief commercial officer.
Clinical-stage biopharma Avalyn named Douglas Carlson as CFO and chief business officer.
Erlanger Behavioral Health Hospital named Matthew Whitley as chief operating officer.
CareDx named John W. Hanna as president and CEO.
Independent pharmaceutical marketing and communications agency RevHealth appointed Stacey Crowley to serve as SVP of growth.
BBDO New York hired Emily Portnoy as its chief strategy officer.
ImmuneSensor Therapeutics named Thomas W. Dubensky, Jr., PhD as CEO.
Akari Therapeutics tapped Samir R. Patel, MD as interim CEO.
Former Massachusetts Institute of Technology and Whitehead Institute of Biomedical Research biologist David Sabatini, who lost his roles after being accused of violating sexual harassment policies in 2021, is working as head of a research group at a new laboratory under the umbrella of IOCB Prague.
Babson Diagnostics established its clinician relations team by adding four new members.
Executive elevations:
Generate:Biomedicines also promoted Lisa Wyman to chief technical operations officer.
Ogilvy appointed Antonis Kocheilas as global chief transformation officer.
Miriam Merad, MD, PhD, was elevated to dean for translational research and therapeutic innovation of the Icahn School of Medicine at Mount Sinai.
Peregrine Market Access promoted Jennifer Schmid and Ronald Deng, PharmD.
Board appointments:
Sandoz shareholders reelected Gilbert Ghostine as chairman of the board of directors and elected Mathai Mammen, Graeme Pitkethly and Michael Rechsteiner as new board members.
The Ad Council appointed 23 new members to its board of directors and promoted Kim Kelleher, chief commercial officer of AMC Networks, to secretary of the board. The organization also added three executives to its Leadership Council.
Violet Aldaia was elected board chair of the Coalition For Healthcare Communication.
Sanofi’s general meeting renewed Rachel Duan and Lise Kingo as members of the board of directors and approved the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent directors.
Bio-Techne added Dr. Judith Klimovsky to its board of directors.
H1 named marketing and technology executive Karen Walker to its board of directors.
Tessellate BIO appointed Sandra Strauss to its scientific advisory board.
Departures:
Due to her appointment as CEO of the Duckhorn Portfolio, Deirdre Mahlan will be stepping down from her role as a non-executive director and chair of Haleon’s audit and risk committee.
Miscellaneous:
Anthony S. Fauci, former chief medical advisor to the President of the United States and director of the National Institute of Allergy and Infectious Diseases, agreed to testify in front of the House panel investigating the nation’s response to the COVID-19 pandemic.
